OTC · THCT
THC Therapeutics, Inc.
$0.00$0.00 (0.0%)
THC Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.3% below the high.
Loading market information…
OTC · UPHL · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
UpHealth, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
UpHealth, Inc.’s next earnings report is currently expected on Nov 24, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow UpHealth, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
UpHealth, Inc. delivers specialized behavioral health services across the Americas, employing scientifically-backed treatments and methodologies. The company directly supports individuals grappling with mental health issues and substance addiction. Its comprehensive array of services encompasses detoxification, inpatient programs, partial hospitalization (PHP), intensive outpatient programs (IOP), traditional outpatient services, and non-clinical recovery housing along with supportive living arrangements. UpHealth, Inc. is headquartered in Delray Beach, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Mar 2, 2023 |
| -$1.82-121.95% vs estimate |
| $40.50M+1.82% vs estimate |
| Q3 2022 | Dec 29, 2022 | -$11.17-1,473.24% vs estimate | $38.67M-5.69% vs estimate |
|---|
| Q2 2022 | Aug 15, 2022 | -$0.90-17.39% vs estimate | $43.67M-2.93% vs estimate |
|---|
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
THC Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.3% below the high.
$0.00$0.00 (0.0%)
Net Medical Xpress Solutions, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.14% below the high.
$0.00$0.00 (0.0%)
Quick-Med Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 37.5% below the high.
$0.00$0.00 (0.0%)
Remedent, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
WellQuest Medical & Wellness Corporation’s quoted price sits in the lower half of its reported 52-week range, 93.55% below the high.
$0.00$0.00 (0.0%)
Kaleido Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.95% below the high.
$0.00$0.00 (0.0%)
Cyclo3pss Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Nemaura Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
